Search results
FDA Approves Bristol Myers Squibb's Combination Therapy For Colorectal Cancer Patients With Certain...
Benzinga via AOL· 2 hours agoFriday, the FDA granted accelerated approval to Bristol Myers Squibb & Co’s (NYSE:BMY) Krazati...
Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Park National Corp OH
ETF DAILY NEWS· 5 days agoPark National Corp OH lowered its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 17.7% during the first quarter, according to its most recent disclosure with ...
Bristol-Myers Squibb stock price forecast: Is the downtrend finally over? | Invezz
Invezz· 5 days agoShares of Bristol-Myers Squibb Co (NYSE:BMY) have had a tumultuous journey since reaching its...
Park Avenue Securities LLC Grows Position in Bristol-Myers Squibb (NYSE:BMY)
ETF DAILY NEWS· 2 days agoPark Avenue Securities LLC raised its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 30.8% during the first quarter, according to its most recent disclosure with ...
Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb
Motley Fool via Yahoo Finance· 6 days agoStill, Pfizer's upcoming bout with the patent cliff for key revenue generators like the...
Pipeline Moves: Approval prospects for BioTissue’s diabetic foot ulcer drug up after Phase III...
Clinical Trials Arena via Yahoo Finance· 9 hours agoBMS completes Phase II HCC trial Bristol Myers Squibb’s BMS-813160 saw its PTSR in hepatocellular...
US FDA approves Bristol Myers' colorectal cancer therapy
Reuters· 3 days agoThe approval under the agency's accelerated process was based on an early- to mid-stage study, in...
Jazz drug for tremor fails study; Radiopharma drug developer ITM swaps CEOs
BioPharma Dive via Yahoo Finance· 3 days agoA medicine Jazz acquired in 2019 missed the goal of a Phase 2 study. Elsewhere, Vanda rejected two...
Amicus Therapeutics opens global HQ in Princeton
NJBIZ· 3 days agoAmicus Therapeutics cut the ribbon last week on a sparkling new global headquarters located on Hulfish Street in Princeton. Founded by John Crowley in...
Day One targets the growing ADC market with MabCare acquisition
Pharmaceutical Technology via Yahoo Finance· 5 days agoDay One has entered a licensing agreement for MTX-13, now called DAY301, a novel antibody drug...